{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:13:44Z","timestamp":1791918824172,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013223","name":"Chongqing Research Program of Basic Research and Frontier Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bmcl.2020.127756","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T12:41:02Z","timestamp":1608813662000},"page":"127756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studies"],"prefix":"10.1016","volume":"34","author":[{"given":"You","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwon Ho","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127756_b0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer \u2019 s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bmcl.2020.127756_b0010","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2019. Attitudes to dementia. 2019. Accessed September 1, 2020. https:\/\/www.alz.co.uk\/research\/ world-report-2019."},{"issue":"4558","key":"10.1016\/j.bmcl.2020.127756_b0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bmcl.2020.127756_b0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer's disease; current status and new perspectives","volume":"2","author":"scarpini","year":"2003","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.bmcl.2020.127756_b0025","doi-asserted-by":"crossref","first-page":"11049","DOI":"10.1073\/pnas.96.20.11049","article-title":"Cellular mechanisms of \u03b2-amyloid production and secretion","volume":"96","author":"Sinha","year":"1999","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127756_b0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adhes Migrat"},{"issue":"6","key":"10.1016\/j.bmcl.2020.127756_b0035","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer Mechanisms and Therapeutic Strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"issue":"29","key":"10.1016\/j.bmcl.2020.127756_b0040","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.2174\/0929867323666160525114026","article-title":"Adamantane \u2013 A Lead Structure for Drugs in Clinical Practice","volume":"23","author":"Spilovska","year":"2016","journal-title":"CMC"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127756_b0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease: multitarget-directed ligands approach for ad treatment","volume":"33","author":"Le\u00f3n","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2020.127756_b0050","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J Med Chem"},{"issue":"01","key":"10.1016\/j.bmcl.2020.127756_b0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int J Neuropsychopharm."},{"key":"10.1016\/j.bmcl.2020.127756_b0060","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","article-title":"Discovery and structure\u2013activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening","volume":"59","author":"Dighe","year":"2016","journal-title":"J Med Chem"},{"issue":"8369","key":"10.1016\/j.bmcl.2020.127756_b0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(84)90116-8","article-title":"Decreased ratio of csf acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease","volume":"323","author":"Arendt","year":"1984","journal-title":"The Lancet"},{"key":"10.1016\/j.bmcl.2020.127756_b0070","doi-asserted-by":"crossref","unstructured":"Hartmann J, Kiewert C, Duysen EG, Lockridge O, Greig NH, Klein J. Excessive Hippocampal Acetylcholine Levels in Acetylcholinesterase-Deficient Mice Are Moderated by Butyrylcholi- nesterase Activity. J Neurochem 2007;100:1421-1429.","DOI":"10.1111\/j.1471-4159.2006.04347.x"},{"key":"10.1016\/j.bmcl.2020.127756_b0075","unstructured":"Greig NH, Yu Q, Brossi A, Soncrant TT, Hausman M. Highly Selective Butyrylcholinesterase Inhibitors for the Treatment and Diagnosis of Alzheimer\u2019s Disease and Dementias. U.S. Patent 20020094999, July 18, 2002."},{"key":"10.1016\/j.bmcl.2020.127756_b0080","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective Butyrylcholinesterase Inhibition Elevates Brain Acetylcholine, Augments Learning and Lowers Alzheimer \u03b2-Amyloid Peptide in Rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127756_b0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2011.07.035","article-title":"Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-\u03b2 peptide in mice","volume":"225","author":"Furukawa-Hibi","year":"2011","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.bmcl.2020.127756_b0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"GIACOBINI","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmcl.2020.127756_b0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase Inhibitors in Alzheimer\u2019s Disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127756_b0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1567205054367838","article-title":"Cholinesterases: Roles in the Brain During Health and Disease","volume":"2","author":"Ballard","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bmcl.2020.127756_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/mp.2013.19","article-title":"APOE and BCHE as modulators of cerebral amyloid deposition: A florbetapir PET genome-wide association study","volume":"19","author":"Ramanan","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bmcl.2020.127756_b0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmcl.2020.127756_b0115","doi-asserted-by":"crossref","first-page":"111259","DOI":"10.1016\/j.mad.2020.111259","article-title":"Neuroinflammation in pathogenesis of Alzheimer's disease: Phytochemicals as potential therapeutics","volume":"189","author":"Vaiserman","year":"2020","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.bmcl.2020.127756_b0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bmcl.2020.127756_b0125","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1471-4159.2009.06175.x","article-title":"Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3- dioxygenase in monocytic cells primed with amyloid beta peptide 1\u201342: implications for the pathogenesis of Alzheimer's disease","volume":"110","author":"Yamada","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmcl.2020.127756_b0130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmcl.2020.127756_b0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol Appl Neurobio"},{"key":"10.1016\/j.bmcl.2020.127756_b0140","doi-asserted-by":"crossref","unstructured":"Wu W, Nicolazzo JA, Wen L, et al. Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer\u2019s disease brain. PLoS One. 2013;8:e59749.","DOI":"10.1371\/journal.pone.0059749"},{"issue":"4","key":"10.1016\/j.bmcl.2020.127756_b0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","article-title":"Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease","volume":"15","author":"Bonda","year":"2010","journal-title":"Redox Rep"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127756_b0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-140414","article-title":"The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease","volume":"43","author":"Yu","year":"2014","journal-title":"JAD"},{"key":"10.1016\/j.bmcl.2020.127756_b0155","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.bmc.2018.02.014","article-title":"Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibiton: The design, synthesi of miconazole analogues targeting Alzheimer's disese","volume":"26","author":"Lu","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2020.127756_b0160","doi-asserted-by":"crossref","unstructured":"Gilson MK, Liu TQ, Baitaluk M, Nicola G, Hwang L, Chong J. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 2016;44:D1045-D1053.","DOI":"10.1093\/nar\/gkv1072"},{"key":"10.1016\/j.bmcl.2020.127756_b0165","doi-asserted-by":"crossref","unstructured":"Kim S, Chen J, Cheng T, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 2019;47:D1102-1109.","DOI":"10.1093\/nar\/gky1033"},{"key":"10.1016\/j.bmcl.2020.127756_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Ko\u0160ak","year":"2018","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2020.127756_b0175","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2020.127756_b0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2020.127756_b0185","doi-asserted-by":"crossref","unstructured":"Chen Y, Lin H, Yang H, et al. Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening. RSC Adv 2017;7:3429\u20133438.","DOI":"10.1039\/C6RA25887E"},{"key":"10.1016\/j.bmcl.2020.127756_b0190","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1021\/jm300260v","article-title":"Rational design of 4-aryl-1,2,3- triazoles for indoleamine 2,3-dioxygenase 1 inhibition","volume":"55","author":"Rohrig","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127756_b0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O -alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127756_b0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2011-110182","article-title":"Targeting oligomers in neurodegenerative disorders: Lessons from \u03b1-synuclein, tau, and amyloid-\u03b2 peptide","volume":"24","author":"Gadad","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bmcl.2020.127756_b0205","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/srep19393","article-title":"Extracellular Tau Oligomers Produce an Immediate Impairment of LTP and Memory","volume":"6","author":"F\u00e1","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2020.127756_b0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127756_b0215","doi-asserted-by":"crossref","unstructured":"Jiang CS, Ge YX, Cheng ZQ, Wang YY, Tao HR, Zhu KK, Zhang H. Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-A\u03b2 Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation. Molecules 2019;24:2568.","DOI":"10.3390\/molecules24142568"},{"key":"10.1016\/j.bmcl.2020.127756_b0220","doi-asserted-by":"crossref","first-page":"127075","DOI":"10.1016\/j.bmcl.2020.127075","article-title":"Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through strucuture-based virtual screening","volume":"30","author":"Joubert","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127756_b0225","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/acs.jmedchem.5b01390","article-title":"Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1","volume":"59","author":"Peng","year":"2016","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20308672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20308672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:37:47Z","timestamp":1760773067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20308672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":45,"alternative-id":["S0960894X20308672"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127756","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127756"}}